Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 23
Filtrar
Más filtros

País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
World J Gastroenterol ; 28(34): 5007-5022, 2022 Sep 14.
Artículo en Inglés | MEDLINE | ID: mdl-36160643

RESUMEN

BACKGROUND: Slow transit constipation (STC) is a common intestinal disease with increasing incidence. STC results from various factors, such as the enteric nervous system and metabolic changes. As a classical formula of traditional Chinese medicine, Ji-Chuan decoction (JCD) has been extensively and effectively used in STC treatment, yet its pharmacological mechanism remains unclear. AIM: To explore the integrated regulatory pattern of JCD against STC through hyphenated techniques from metabolism, network pharmacology and molecular methods. METHODS: STC model mice were generated by intragastric administration of compound diphenoxylate (10 mg/kg/d) for 14 d. The STC mice in the low dose of JCD (3.04 g/kg), middle dose of JCD (6.08 g/kg) and high dose of JCD (12.16 g/kg) groups were orally administered JCD solution once a day for 2 wk. The acetylcholine (ACH) level was examined by enzyme-linked immunosorbent assay. The pathological features of colon tissue were observed by hematoxylin and eosin staining. The differentially expressed metabolites and metabolic pathways were tested by nontargeted metabolomics. The main targets and core ingredients of JCD were identified by network pharmacology, and the expression of AKT was confirmed by immunohistochemistry. Finally, the pathways involved in JCD treatment were predicted using a combination of differentially expressed metabolites and targets, and intestinal glial cell apoptosis was demonstrated by immunofluorescence. RESULTS: JCD significantly promoted intestinal motility, increased the levels of the excitatory neurotransmitter ACH and reduced intestinal inflammation in STC mice. Untargeted metabolomics results showed that JCD significantly restored metabolic dysfunction and significantly affected taurine and hypotaurine metabolism. Network pharmacology and molecular experiments showed that JCD regulates AKT protein expression, and the core component is quercetin. Combined analysis demonstrated that apoptosis may be an important mechanism by which JCD relieves constipation. Further experiments showed that JCD reduced enteric glial cell (EGC) apoptosis. CONCLUSION: This work demonstrated that reducing EGC apoptosis may be the critical mechanism by which JCD treats STC. These findings call for further molecular research to facilitate the clinical application of JCD.


Asunto(s)
Acetilcolina , Difenoxilato , Animales , Apoptosis , Estreñimiento , Tránsito Gastrointestinal , Ratones , Neuroglía/metabolismo , Proteínas Proto-Oncogénicas c-akt , Quercetina , Taurina
2.
Zhongguo Ying Yong Sheng Li Xue Za Zhi ; 38(6): 776-781, 2022 Nov.
Artículo en Chino | MEDLINE | ID: mdl-37308434

RESUMEN

Objective: To investigate the effects of Mijian Daotong Bowel Suppository (MJDs) on the compound diphenoxylate induced constipation model of male rats and its mechanisms. Methods: Sixty SD male rats were randomly divided into blank group, model group, positive group and MJDs group. The constipation model was established by using compound diphenoxylate gavage. The rats in blank group and model group were treated with saline by enema, the rats in positive group and MJDs group were given Kaisailu and honey decoction laxative suppository by enema, respectively, once a day for 10 days. The body weight, fecal water content, gastric emptying rate (GER) and carbon ink propulsion rate (CIPR) of rats were observed during modeling and administration. The effects of MJDs on the pathological changes of colon tissue in constipation rats were investigated by hematoxylin-eosin (HE) staining. The effect of MJDs on 5-hydroxytryptamine (5-HT) in the colon of constipation rats was investigated by ELISA kit. The effects of MJDs on the expressions of aquaporins 3 (AQP3) and aquaporins 4 (AQP4) in the colon of constipation rats were detected by immunohistochemistry. Results: After 10 days of administration, compared with the blank group, the body weight, fecal water content, carbon ink propulsion rate and colon 5-HT content in the model group were decreased significantly, while the expression levels of AQP3 and AQP4 in the colon were increased significantly (P<0.05, P<0.01). Compared with the model group, the fecal water content and colon 5-HT content in the positive group were increased significantly, and the expressions of AQP3 and AQP4 in the colon were decreased significantly. The body weight, fecal water content and colon 5-HT content in the MJDs group were increased significantly, and the expressions of AQP3 and AQP4 was decreased significantly (P<0.05, P<0.01). Compared with the positive group, the fecal water content of the MJDs group was decreased significantly, and the expressions of AQP3 and AQP4 in the colon of the MJDs group was decreased significantly (P<0.05, P<0.01). Gastric emptying rate was not statistically significant difference between the groups. Conclusion: MJDs has good therapeutic effects on constipation, and its mechanisms may be related to up-regulating the content of 5-HT in the colon and down-regulating the expressions of AQP3 and AQP4 in the colon.


Asunto(s)
Acuaporinas , Laxativos , Masculino , Animales , Ratas , Difenoxilato , Serotonina , Estreñimiento , Peso Corporal , Carbono
3.
Food Res Int ; 143: 110273, 2021 05.
Artículo en Inglés | MEDLINE | ID: mdl-33992373

RESUMEN

Slow transit constipation (STC) has become an epidemic medical problem. There are several kinds of drugs for constipation; however, each drug has its limitations. The gut microbiota has a close relationship with STC. Lactulose is an effective drug for constipation because it is a kind of bulking laxative and microbioecologic, and it relieves the syndromes of STC. We found that the Chinese Herb Solid Drink (CHSD), which contains medicine food homologous materials such as psyllium husk, sweetalmond, semen sesami nigrum, and hemp seed, has a similar effect on relieving constipation as lactulose, although it has different effects on the gut microbiota. We investigated the mechanisms of CHSD in rats with STC, induced by diphenoxylate, via constipation index and enzyme linked immunosorbent assay (ELISA) analyses using serum and 16S rDNA amplicon and gas chromatography-mass spectroscopy (GC-MS). CHSD enhanced the relative abundance of some types of gut microbiota, such as Blautia, Ruminococcus, Roseburia, Coprococcus, Lachnospira, and Phascolarctobacterium, while lactulose enhanced the relative abundance of Blautia, Phascolarctobacterium, Eubacterium, and Akkernansia in diphenoxylate-induced STC rats. Both CHSD and lactulose enhanced the level of short-chain fatty acids in the faeces of rats; however, the composition of those were different between the two drugs. From the perspective of the gut neuroendocrine system, both CHSD and lactulose could elevate neurotransmitters, such as motilin (MTL) and substance P (SP), which promote intestinal peristalsis and reduce the expression of vasoactive intestinal peptide, which inhibits intestinal peristalsis in the serum of STC rats. CHSD could elevate gastrin expression, which also promoted intestinal peristalsis in serum, while lactulose did not have this effect. Our findings suggest that CHSD may be an effective and safe therapeutic choice for STC.


Asunto(s)
Microbioma Gastrointestinal , Preparaciones Farmacéuticas , Animales , China , Estreñimiento , Difenoxilato , Lactulosa , Ratas
4.
Food Funct ; 10(3): 1513-1528, 2019 Mar 20.
Artículo en Inglés | MEDLINE | ID: mdl-30785176

RESUMEN

Mulberry (Morus atropurpurea) has long been used to treat gastro-intestinal ailments; however, the functional basis of its therapeutic effects remains unclear. The aim of this study was to measure the effects of mulberry (administered by gavage) on diphenoxylate-induced constipation in mice and elucidate the mechanisms underlying these effects using constipation and physicochemical indexes, histological morphology and 16S rDNA amplicon analysis of fecal microbiota. Sixty Kunming mice were randomly divided into the following six groups (n = 10 per group): normal control, constipation model, positive control, and low-, mid- and high-dose mulberry groups. After 14 days of treatment, constipation was induced over 5 days and measurements were conducted. The results show that mulberry treatment prevented constipation by increasing the fecal water content, shortening the first red fecal defecation time, promoting gastric evacuation, and increasing the gastric-intestinal transit rate (P < 0.05). Compared with the constipation model group, the mulberry-treated groups showed decreased aquaporin gene expression (Aqp3, Aqp4, Aqp8 and Aqp9), decreased serum levels of inhibitory neurotransmitters (nitric oxide and vasoactive intestinal peptide) (P < 0.05), and increased serum levels of excitability neurotransmitters (acetyl choline, substance P, and motilin). The histological morphology of the colon showed that mulberry treatment increased the number of mucus cells (P < 0.05). Mulberry treatment also increased the concentrations of acetic, propionic, butyric, valeric and isovaleric acids (P < 0.05), increased the abundance of Lactobacillus and Bifidobacterium in feces, and decreased the abundance of Helicobacter and Prevotellaceae in feces. Our findings indicate that mulberry consumption effectively prevents constipation in mice and is a promising therapeutic candidate for constipation.


Asunto(s)
Estreñimiento/inducido químicamente , Difenoxilato/toxicidad , Frutas/química , Microbioma Gastrointestinal/efectos de los fármacos , Morus/química , Animales , Estreñimiento/dietoterapia , Ratones
5.
J Med Food ; 15(10): 930-5, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23039112

RESUMEN

Banana oligosaccharides (BOS) were extracted with water, and then separated and purified using column chromatography. Gel penetration chromatography was used to determine the molecular weights. Thin layer chromatogram and capillary electrophoresis were employed to analyze the monosaccharide composition. The indican bond and structure of the BOS molecule were determined using Fourier transform infrared spectroscopy and nuclear magnetic resonance. Results showed that BOS were probably composed of eight ß-D-pyran glucose units linked with 1→6 indican bonds. The laxative effects of BOS were investigated in mice using the method described in "Handbook of Technical Standards for Testing and Assessment of Health Food in China." The length of the small intestine over which a carbon suspension solution advanced in mice treated with low-, middle-, and high-dose BOS was significantly greater than that in the model group, suggesting that BOS are effective in accelerating the movement of the small intestine.


Asunto(s)
Laxativos/farmacología , Musa/química , Oligosacáridos/química , Oligosacáridos/farmacología , Animales , China , Cromatografía en Gel , Cromatografía en Capa Delgada , Difenoxilato/farmacología , Electroforesis Capilar , Intestino Delgado/efectos de los fármacos , Espectroscopía de Resonancia Magnética , Ratones , Peso Molecular , Oligosacáridos/aislamiento & purificación , Espectroscopía Infrarroja por Transformada de Fourier
6.
Fitoterapia ; 81(1): 72-4, 2010 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19695314

RESUMEN

The bioassay guided fractionation of the n-hexane extract of the seeds of Murraya koenigii Spreng (Rutaceae) resulted in the isolation of three bioactive carbazole alkaloids, kurryam (I), koenimbine (II) and koenine (III). The structures of the compounds were confirmed from their (1)H-, (13)C-, and 2D-NMR spectral data. Of the three compounds (I) and (II) exhibited significant inhibitory activity against castor oil-induced diarrhoea and PGE(2)-induced enteropooling in rats. The compounds also produced a significant reduction in gastrointestinal motility in the charcoal meal test in Wistar rats.


Asunto(s)
Antidiarreicos/uso terapéutico , Diarrea/tratamiento farmacológico , Alcaloides Indólicos/uso terapéutico , Fitoterapia , Rutaceae/química , Animales , Antidiarreicos/aislamiento & purificación , Antidiarreicos/farmacología , Aceite de Ricino , Catárticos , Diarrea/inducido químicamente , Dinoprostona , Difenoxilato , Evaluación Preclínica de Medicamentos , Femenino , Motilidad Gastrointestinal/efectos de los fármacos , Alcaloides Indólicos/aislamiento & purificación , Alcaloides Indólicos/farmacología , Masculino , Estructura Molecular , Oxitócicos , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Ratas , Ratas Wistar , Semillas/química
7.
Artículo en Inglés | AIM | ID: biblio-1256199

RESUMEN

Rhus semialata Murr. (Anacardiaceae) is a deciduous tree of north eastern India. The fruit of this plant is traditionally used to control diarrhoea and dysentery. The Present study was undertaken to evaluate anti-diarrhoeal potency of methanol extract of fruits of R. semialatalts indicated that the methanol extract of the fruits of R. semialata possesses significant anti-diarrhoeal effect and substantiated the use of this herbal remedy as a non-specific treatment for diarrhoea in folk medicine


Asunto(s)
Antidiarreicos , Difenoxilato , Extractos Vegetales , Ratas , Rhus
8.
Wei Sheng Yan Jiu ; 29(6): 385-6, 2000 Nov.
Artículo en Chino | MEDLINE | ID: mdl-12520963

RESUMEN

Diphenoxylate was administered to mice at the dose of 5 mg/kg BW for the development of peristaltic inhibition model for formulating the examination procedure of health foods. An ink solution containing 5% charcoal was then administered 30 minutes later. The length of ink progradation of the small intestine of mice was calculated 25 minutes after the administration of ink. The results in this model was stable and reliable, and it was recommended to use this model to verify the function of health foods.


Asunto(s)
Suplementos Dietéticos , Modelos Animales de Enfermedad , Peristaltismo , Animales , Estreñimiento/inducido químicamente , Difenoxilato , Ratones , Distribución Aleatoria
9.
Rev Gastroenterol Mex ; 59(2): 139-46, 1994.
Artículo en Inglés | MEDLINE | ID: mdl-7991967

RESUMEN

The successful management of fecal incontinence requires an understanding of anorectal function, careful delineation of the disorder by a detailed history and physical examination, and specialized studies of anorectal and pelvic floor function in selected patients. These studies include anorectal manometry, dynamic radiographic studies of the anorectum, pelvic floor neurophysiologic tests and anal endosonography. Therapeutic options include dietary modifications, behavioral programs, pharmacologic agents and surgery. Currently available diagnostic tests should result in optimal management of these patients.


Asunto(s)
Incontinencia Fecal/fisiopatología , Incontinencia Fecal/terapia , Anciano , Canal Anal/fisiopatología , Niño , Dieta , Difenoxilato/uso terapéutico , Enema , Incontinencia Fecal/cirugía , Femenino , Humanos , Loperamida/uso terapéutico , Masculino , Manometría , Persona de Mediana Edad , Diafragma Pélvico/inervación , Diafragma Pélvico/fisiopatología , Radiografía , Recto/diagnóstico por imagen , Recto/fisiopatología
10.
J Pharm Pharmacol ; 45(12): 1082-4, 1993 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-7908978

RESUMEN

The opiate antidiarrhoeal drugs loperamide (0.6 mg kg-1, i.p.) or difenoxin (0.77 mg kg-1, s.c.), were administered in an anaesthetic mixture (pentobarbitone 60 mg kg-1) to rats. A length of jejunum (approx. 30 cm) was cannulated, washed and then perfused with iso-osmotic saline for 20 min. The perfusion commenced 50 min after drug administration and continued for 20 min. The perfusates were collected for analysis of fluid transport rates and antidiarrhoeal drug content. These doses of the antidiarrhoeals caused marked inhibition of intestinal fluid secretion induced by intra-arterial infusion of vasoactive intestinal peptide. However, neither of the antidiarrhoeal drugs were detected in the intestinal perfusates (< 0.5 ng by HPLC). The results indicate that loperamide and difenoxin have a different pharmacokinetic profile compared with that previously found for morphine under the same conditions.


Asunto(s)
Antidiarreicos/farmacocinética , Difenoxilato/análogos & derivados , Mucosa Intestinal/metabolismo , Loperamida/farmacocinética , Narcóticos/farmacocinética , Absorción , Animales , Calibración , Aceite de Ricino , Cromatografía , Diarrea/inducido químicamente , Diarrea/tratamiento farmacológico , Difenoxilato/farmacocinética , Femenino , Secreciones Intestinales/efectos de los fármacos , Masculino , Ratas , Ratas Wistar , Péptido Intestinal Vasoactivo/antagonistas & inhibidores , Péptido Intestinal Vasoactivo/farmacología
13.
Eur J Pharmacol ; 78(3): 375-7, 1982 Mar 12.
Artículo en Inglés | MEDLINE | ID: mdl-6121713

RESUMEN

Several neuroleptics known to bind to calmodulin were tested for anti-diarrheal activity and were compared with the opiate anti-diarrheals loperamide and diphenoxylate. All inhibited the intestinal fluid secretion induced by 16,16-dimethyl prostaglandin E2 and castor oil-induced diarrhea in rats as a function of dose, the order of potency being loperamide approximately equal to diphenoxylate greater than chlorpromazine greater than promethazine greater than amitriptyline. The opiates loperamide and diphenoxylate were found to compete with [3H]trifluoperazine binding to calmodulin in the presence of calcium. These opiates were approximately 3 times more potent inhibitors of [3H]trifluoperazine binding than chlorpromazine. A positive correlation between calmodulin binding and anti-diarrheal activity was demonstrated.


Asunto(s)
Antidiarreicos/metabolismo , Proteínas de Unión al Calcio/metabolismo , Calmodulina/metabolismo , 16,16-Dimetilprostaglandina E2/farmacología , Animales , Antipsicóticos/farmacología , Líquidos Corporales/metabolismo , Aceite de Ricino , Diarrea/fisiopatología , Difenoxilato/farmacología , Femenino , Mucosa Intestinal/metabolismo , Loperamida/farmacología , Unión Proteica , Ratas , Ratas Endogámicas
15.
J Pharmacol Exp Ther ; 210(3): 327-33, 1979 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-480185

RESUMEN

Three synthetic antidiarrheals, diphenoxylate, loperamide and SC 27166, and two narcotics, morphine and codeine, were evaluated in rats by the intravenous and oral route for specificity and duration of their antidiarrheal, opiate-like and acute toxic effects. The activity in the castor oil test, the tail withdrawal test and the acute toxicity test was used to determine the relative antidiarrheal specificity and relative safety margins. An analysis of animal and clinical data indicate these tests to be excellent indicators of clinical usefulness and specificity. Intravenously, all five agents induced opiate-like central effects, loperamide and SC 27166 at near toxic doses only. When administered orally loperamide and SC 27166 were devoid of opiate-like central nervous system activity. Analysis of the plasma levels after oral loperamide indicated that this drug does not attain a concentration high enough to induce opiate-like central effects. All agents were effective antidiarrheals by the oral route with loperamide being the most potent (ED50 = 0.15 mg/kg), longest acting (ED50 8 hr = 1.81 mg/kg) and most specific (relative antidiarrheal specificity, 8 hr greater than or equal to 88) and having the greatest relative safety margin (8 hr = 102).


Asunto(s)
Antidiarreicos/farmacología , Narcóticos , Administración Oral , Animales , Compuestos Bicíclicos con Puentes , Aceite de Ricino/antagonistas & inhibidores , Codeína/farmacología , Difenoxilato/farmacología , Relación Dosis-Respuesta a Droga , Inyecciones Intravenosas , Dosificación Letal Mediana , Loperamida/farmacología , Masculino , Morfina/farmacología , Oxadiazoles/farmacología , Ratas , Tiempo de Reacción/efectos de los fármacos
18.
Gut ; 19(5): 377-83, 1978 May.
Artículo en Inglés | MEDLINE | ID: mdl-658767

RESUMEN

The effect on ileostomy function of codeine phosphate, Lomotil, or Isogel was tested in 20 subjects at home living a normal life, studied over two three-day periods on and off treatment. Codeine phosphate 60 mg three times daily was associated with a reduction in the mean total weight of ileostomy output and the ileostomy outputs of water, sodium, and potassium (p < 0.05). The proportion of faecal solids increased on codeine and the effluent appeared thicker but the output of faecal solids remained unchanged. Mean faecal fat increased on codeine. The transit rate from mouth to stoma was slower in four of the five subjects on codeine and a further two subjects withdrew from the trial with temporary intestinal obstruction while on the drug. Lomotil two tablets three times daily was associated with a small and statistically not quite significant fall in the mean total weight of ileostomy output and the ileostomy output of water. Sodium and potassium outputs in the effluent fell on Lomotil (p < 0.05) but the other parameters remained unchanged. Isogel 15 ml three times daily was associated with an increase in the mean total weight of ileostomy output and the ileostomy outputs of water, sodium, potassium, and faecal solids (p < 0.01). Although the effluent looked more viscid on Isogel, the proportion of faecal solids was unchanged. These results suggest that codeine phosphate has a beneficial effect on ileostomy function, reducing the loss of water and electrolytes, while Lomotil has a similar but less effective action in the dosage tested. By contrast, Isogel increases the ileostomy loss of water and electrolytes and will aggravate their depletion in patients with excessive fluid effluents. The increase in faecal fat associated with taking codeine phosphate suggests that it should be stopped before collecting specimens for faecal fat estimations.


Asunto(s)
Atropina/uso terapéutico , Codeína/análogos & derivados , Diarrea/tratamiento farmacológico , Difenoxilato/uso terapéutico , Ileostomía , Ácidos Isonipecóticos/uso terapéutico , Complicaciones Posoperatorias/tratamiento farmacológico , Psyllium/uso terapéutico , Adolescente , Adulto , Anciano , Codeína/uso terapéutico , Combinación de Medicamentos , Femenino , Motilidad Gastrointestinal/efectos de los fármacos , Humanos , Masculino , Persona de Mediana Edad
19.
Am J Dig Dis ; 22(4): 327-32, 1977 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-855849

RESUMEN

Commonly used antimotility and antidiarrheal drugs were administered to six ileostomized subjects to determine whether their normal ileal excreta and that induced by prune juice could be altered. A total of 49 studies were performed, 21 with and 28 without prune juice. Bismuth subgallate was the only drug which significantly reduced the normal ileal excreta (P less than 0.05). Codeine sulfate decreased the ileal excreta in two of three subjects in either type of study. The third subject was a nonresponder to drugs. Deodorized tincture of opium (DTO) and diphenoxylate (Lomotil) were also effective in some subjects. Propantheline, tincture of belladonna, Sorboquel, and Kaopectate did not appear to decrease ileal excreta. Calcium carbonate, on the other hand, increased ileal excreta; fat excretion was also increased.


Asunto(s)
Antidiarreicos/farmacología , Difenoxilato/farmacología , Íleon/fisiopatología , Ácidos Isonipecóticos/farmacología , Opio/farmacología , Parasimpatolíticos/farmacología , Adulto , Anciano , Alcaloides de Belladona/farmacología , Bismuto/farmacología , Carbonato de Calcio/farmacología , Codeína/farmacología , Femenino , Frutas , Motilidad Gastrointestinal/efectos de los fármacos , Humanos , Ileostomía , Íleon/efectos de los fármacos , Secreciones Intestinales/efectos de los fármacos , Caolín/farmacología , Masculino , Propantelina/farmacología , Equilibrio Hidroelectrolítico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA